Access to healthcare and costs depend on where one lives in the United States. Chronic eye disease doesn’t vary from place to place. But as recent Medicare data show, the way that doctors’ treat it does, and those choices have huge effects on the U.S. and personal budgets.
The brightest reds show places where the vast majority of the money spent in treating chronic eye disease is spent on Lucentis; the deepest blues, shows places where most of the money spent treating the disease is spent on its cheaper alternatives.
Read the rest of the article and check out the maps here.
Juhi Mawla, Intern, firstname.lastname@example.org